CD19 / CD20
Assets acting on this target.
- Class
- Bispecific chimeric antigen receptor (CAR) T-cell therapy targeting CD19 and CD20
- Notes
- mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT06462144 names the target); source: https://clinicaltrials.gov/study/NCT06462144